https://www.ema.europa.eu/en/medicines/human/EPAR/vumerity 2022 false false false Netherlands French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation Diroximel Fumarate Diroximel Fumarate diroximel fumarate multiple sclerosis, relapsing-remitting adult drug approval europe administration, oral pregnancy breast feeding drug interactions aged drug evaluation, preclinical
--- https://www.has-sante.fr/jcms/p_3322980/fr/vumerity-diroximel 2022 false false false France treatment outcome insurance, health, reimbursement administration, oral multiple sclerosis, relapsing-remitting diroximel fumarate Diroximel Fumarate Diroximel Fumarate evaluation of the transparency committee